Clinical Guidelines on Nonalcoholic Fatty Liver Disease

To the Editor: In their JAMA Clinical Guideline Synopsis, Dr Leung and colleagues provide an overview of the 2022 American Association of Clinical Endocrinology (AACE) and American Association for the Study of Liver Diseases (AASLD) guideline for the management of nonalcoholic fatty liver disease (NAFLD) in primary care and endocrinology clinical settings. Notable recommendations include screening for NAFLD and advanced fibrosis in high-risk patients and treating patients with nonalcoholic steatohepatitis (NASH) and type 2 diabetes.
Source: JAMA - Category: General Medicine Source Type: research